
1 minute read
New GP guidance
from Issue 40
to encourage networking and shared care where necessary. Integrated care systems will be looking at system-wide delivery of health care. Primary care networks, often seen as the frontline delivery units of the system, may want to consider employing GPwERs or looking at dual employment between practices and hospital clinics for shared learning. Models of care may vary across the country with some GPs working remotely from home, some in clinics, and some in the community.
We are not aware of another framework of this kind in place throughout Europe, so this may be of interest to other healthcare systems. We are aware that we have good examples of GPs being supported in hospital clinics and other areas, however, there have also been some GPs who have completed further training such as diplomas and MScs who have struggled to find a place to work or units to link to. We hope this process may help facilitate such linkages, the sharing of good practice, and lessening of the isolation that colleagues in the community may feel.
Advertisement
There will be a BSACI webinar in November which will cover this new accreditation process alongside details on the IQAS accreditation system. We see this new GPwER accreditation as a companion to IQAS. Increasingly, GP colleagues look to work in specialist fields and this document creates a pathway to enter working in Allergy with clear governance and demonstration of learning and competencies. We anticipate an increase in GPs taking up such work which will assist the workforce crisis in Allergy.
Dr Matt Doyle, who will be one of the first GPs to undergo the accreditation, said “this is an important step in improving the governance for Primary Care colleagues who wish to develop a specialist interest in Allergy and I welcome the opportunity to take part”.
The Adrenaline auto-injector prescription for patients at risk of anaphylaxis: BSACI guidance for primary care is available on our website at www.bsaci.org/guidelines/ primary-care-guidelines/
The guidance has been written for a primary care healthcare professional managing a patient who has either experienced anaphylaxis or a milder allergic reaction where they may be at risk of anaphylaxis in the future. To view the letter in Clinical & Experimental Allergy visit https://onlinelibrary.wiley.com/doi/10.1111/cea.14325